Ann: Kazia completes recruitment to Cantrixil Phase 1 trial, page-57

The more desperate poster become the more shrill they become. NOX 40 cents. KZA was not the first large seller and who knows who is the next lining up now. We have no liquidity at the moment. But that will change in the coming months if the data brings home the bacon. If not we are toast. But at least we have IP secured, 6 trials now a drug that seems to be working as a mono therapy and may prove even more valuable in combinations.